IN8BIO, INC. Shares Outstanding (Cover Page)
IN8BIO, INC. (INAB) had Shares Outstanding (Cover Page) of 9.86 million shares as of 2026-08-03, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-08-03: Entity Common Stock, Shares Outstanding 9.86M shares.
- 2026-05-04: Entity Common Stock, Shares Outstanding 9.85M shares.
- 2025-11-03: Entity Common Stock, Shares Outstanding 4.63M shares.
- 2025-08-03: Entity Common Stock, Shares Outstanding 4.54M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 9.86M shares 10-Q · filed 2026-08-06 |
| 2026-05-04 | 9.85M shares 10-Q · filed 2026-05-07 |
| 2025-11-03 | 4.63M shares 10-Q · filed 2025-11-06 |
| 2025-08-03 | 4.54M shares 10-Q · filed 2025-08-07 |
| 2025-05-02 | 90.77M shares 10-K/A · filed 2025-05-07 |
| 2024-11-11 | 72.48M shares 10-Q · filed 2024-11-12 |
| 2024-08-07 | 46.79M shares 10-Q · filed 2024-08-08 |
| 2024-05-06 | 44.12M shares 10-Q · filed 2024-05-09 |
| 2024-03-14 | 43.29M shares 10-K · filed 2024-03-14 |
| 2023-11-06 | 31.99M shares 10-Q · filed 2023-11-09 |
| 2023-08-07 | 31.60M shares 10-Q · filed 2023-08-10 |
| 2023-05-07 | 29.75M shares 10-Q · filed 2023-05-12 |
| 2023-03-28 | 24.94M shares 10-K · filed 2023-03-30 |
| 2022-11-01 | 24.50M shares 10-Q · filed 2022-11-10 |
| 2022-08-07 | 18.84M shares 10-Q · filed 2022-08-12 |
| 2022-05-03 | 18.84M shares 10-Q · filed 2022-05-12 |
| 2022-03-10 | 18.81M shares 10-K · filed 2022-03-17 |
| 2021-11-03 | 18.75M shares 10-Q · filed 2021-11-10 |
| 2021-09-07 | 18.75M shares 10-Q · filed 2021-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |